Highlights from the 17th BGICC: Day 2 of Breast-Gynecological International Cancer Conference
Day 2 of the International Cancer Conference on Friday, January 24th, featured a series of keynote sessions and discussions that brought together leading experts in oncology from around the world.
With 5,000 participants from over 50 countries, BGICC has grown to become a global hub for knowledge-sharing and collaboration in cancer care. Founded to advance research in breast and gynecological oncology, the conference provides an unparalleled opportunity for specialists to exchange ideas, discuss cutting-edge research, and shape the future of oncology.
Morning Sessions
The morning kicked off with sessions on breast cancer, focusing on prevention, diagnosis, and advanced treatment strategies:
1. Cancer Risk-Reducing Strategies in Women with BRCA Pathogenic Variants
- Presented by Prof. Alena Savanevich (Belarus), this session explored preventive strategies for women carrying BRCA mutations, emphasizing risk-reduction techniques.
2. Artificial Intelligence in Breast Cancer Diagnosis
- Dr. Youmna Kassab (Egypt) delivered an engaging talk on how AI enhances the identification of non-palpable breast carcinomas, showcasing its potential to revolutionize early detection.
3. Functionalized Amygdalin-Nano for Enhanced Chemo- and Radio-sensitivity
- A groundbreaking presentation by Dr. Rokaya Maarouf (Egypt) highlighted how targeting the P38/MAPK immune-modulator signaling pathway can improve breast cancer treatment outcomes.
4. Hereditary Breast and Ovarian Cancer Overview
- Prof. Hiba Moukadem (Lebanon) provided valuable insights into hereditary cancer syndromes, with a focus on data from Lebanon.
The Q/A session that followed allowed experts to dive deeper into these significant advancements, fostering discussions on clinical implications.
Challenging Situations in Breast Cancer
A standout session moderated by Prof. Emad Shash (Egypt) brought global experts together to discuss local recurrence in breast cancer, a particularly challenging clinical scenario. Highlights included:
- Prof. Charles Balch (USA): Discussed advanced management of recurrent axillary metastases.
- Prof. Roberto Orecchia (Italy): Delivered insights on re-irradiation strategies, emphasizing safety and efficacy.
- Prof. Jennifer Harvey (USA): Presented solutions for imaging difficulties in suspected recurrences.
- Prof. Joseph Gligorov (France): Explored systemic treatment options for isolated local recurrences.
This session underscored multidisciplinary approaches and cutting-edge techniques to tackle recurrences effectively.
Keynote Lecture: HER2+ MBC Therapy
One of the highlights of the day was the keynote lecture delivered by Prof. Giuseppe Curigliano (Italy) on balancing effectiveness and toxicity in HER2-positive metastatic breast cancer therapy. His talk, focusing on the duration of ADC (antibody-drug conjugate) therapy, captivated the audience and sparked meaningful discussions.
The Axillary Dilemma
The afternoon saw an interactive session on axillary management in breast cancer, moderated by Prof. Omar Z. Youssef (Egypt). Key topics included:
- Sentinel Lymph Node Biopsy (sLN): Advances and challenges in LMIC settings.
- Post-Neoadjuvant Therapy Management: Strategies for less invasive interventions.
- Radiation vs. Surgery: A comparative discussion for cases with minimal lymph node involvement.
The panel addressed the complexity of axillary management with a multidisciplinary perspective, offering practical insights for oncologists.
AI and Big Data in Oncology
The evening sessions highlighted the transformative role of artificial intelligence and big data in oncology:
1. Future of Oncology Management Using Big Data and AI
- A visionary keynote by Prof. Fabrice Andre (France) emphasized how data-driven approaches are shaping the future of cancer care.
2. AI Applications in Oncology:
- Prof. Niketa Chotai (Singapore): Explored AI in breast imaging, discussing its integration into routine practice.
- Prof. Frédérique Penault-Llorca (France): Shared insights on AI’s role in pathology, particularly in breast cancer diagnostics.
- Prof. Roberto Orecchia (Italy): Addressed AI applications in radiotherapy.
3. Social Media in Oncology:
- Prof. Gevorg Tamamyan (Armenia) delivered an engaging presentation on the impact of social media on oncology awareness, education, and outreach.
This session demonstrated the intersection of technology, medicine, and communication, emphasizing the importance of innovation in cancer care.
Gynaecological Oncology and Pathology
The day also included impactful sessions on gynaecological oncology and pathology, with key discussions on ovarian cancer and cervical cancer. Notable topics included:
- AI-Enabled Neoantigen Specific Cell Therapy
- Presented by Prof. Ahmed Ashour, showcasing its potential to target minimal residual disease in ovarian cancer.
- Sentinel Lymph Node Concept in Cervical Cancer
- Delivered by Prof. Murat Gultekin, discussing its relevance in staging and treatment.
- Lymphomas of the Gynecologic Tract
- Prof. Kamran Mirza (USA) provided a detailed update on this rare but significant entity.
Final Takeaways
Day 2 was a resounding success, offering a mix of groundbreaking research, technological advancements, and multidisciplinary approaches. The most memorable sessions included:
- Prof. Giuseppe Curigliano’s keynote on HER2+ MBC therapy.
- The interactive discussion on axillary management.
- The AI and Big Data session, with inspiring contributions from global leaders.
These sessions set the stage for further collaborations, innovations, and advancements in cancer care.
Here are a few not to miss highlights from BGICC 2025 picked by OncoDaily:
“Highlights from BGICC 2025 Workshops – The 17th Breast-Gynecological International Cancer Conference (BGICC) with a series of groundbreaking workshops led by world-renowned experts!
Our cameras were there to capture every insightful moment, from interactive sessions to knowledge-sharing and hands-on experiences that set the tone for an exceptional conference.
Venue: Hilton Cairo Heliopolis
Stay tuned as we continue to document every highlight of this transformative event. Watch this space for more updates, photos, and behind-the-scenes moments!”
“Breast Gynecological & Immunooncology International Cancer Conference-BGICC is a GREAT success! Several thousand participants, outstanding program and speakers, excellent organization! It is a great pleasure and honor for the OncoDaily team to be present here and to cover this amazing event! My sincere congratulations to Prof. Hesham ElGhazaly and the whole team behind it! It is really outstanding, no words.”
“During my speech at the high-level delegation meeting on the sideline of BGICC, to announc the formation of the regional alliance of the Oncology Accociations, witnessed by the leaders of Chinese, American, and Russian Oncology accociations. We emphasized that fostering regional partnerships and sharing expertise among Arab nations is a critical step in tackling the increasing challenges posed by cancer. Collaboration between health institutions and research centers plays a key role in accelerating technology transfer, implementing global best practices, and strengthening the capabilities of local medical professionals.”
“I had the privilege of attending the 17th BGICC Breast-Gynecological & Immuno-oncology International Cancer Conference this year, where I gained valuable insights into the latest research and advancements in the treatment of cancers, especially breast and gynecological cancers.
The conference provided an incredible opportunity to connect with leading experts in the field and exchange ideas on innovative treatments and best practices.”
“Praise and thanks to God it was a beautiful day we thank God for his bounty and generosity
We thank Professor Sarah Hassan for giving us the opportunity to lecture and attend the conference and for the organization and arrangement and the details of the preparation to know what she went through during the past days Thank you to her for everything
I thank the best doctors I knew at work and in our life abroad from the first moment I met them in order that I met them Dr. Shayma Mostafa and Dr. Aya Mohamed and Dr. Reham Mamdouh and I appreciate very much their encouragement and education and we will never forget their favor.
And I am proud to be with my work friends with this greatness of science and beautiful soul God bless us always and I am grateful to them for everything Jomana osama, Fatma Naser Arafa, Dalia Hussein, Gehad Mohamed, Basant Essam.
And our dear friend
Ahmed El Sayed & Dr. Ahmed Khattab
Thanks to our unity, our laboratory, and our great center for everything Molecular Genomics Unit – MASRI
And I would like to express my joy and thanks to all the people that we met because of the conference before and after or in the trainings or through the unit of trainees companies researchers students and all wonderful people Thank you all for your personality and for your knowledge and your efforts and thanks to all the people to you the last lecture with us I had the honor to know you and good luck always and excuse me if I forgot anyone
Thank you all
Finally, with all due respect and appreciation to our professor and leader, Professor Hisham El-Ghazali, director of the Ain Shams Medical Research Center and the great leader of the BGICC conference. And the picture that I wait every year and thank God its greatness increased with the presence of Prof Loay God bless you in your knowledge.
Thanks to all and there are respectable people I met but unfortunately I cant find them I hope to see you in good health always
Every year and you are good and God willing we meet fine every year and every day.”
“The burning topic. The role of social media in oncology presented by Prof. Gevorg Tamamyan at BGICC2025.
And here’s where OncoDaily stands out—changing the landscape of oncology media globally.”
“Had a great time at 17th BGIICC, and Oncothoracic international congress Ontic; sharing ideas during my talk and connecting with so many brilliant colleagues.
Huge thanks and congrats to Hesham ElGhazaly, Ola Khorshid,Hagar ElGhazawy, Nermean Mostafa and team for hosting such a fantastic event.”
“As I reflect upon the past one year at the WHO Global Breast Cancer Initiative I am overwhelmed by the facts..that this past year alone, 2.3million women have been diagnosed with breast cancer and 670,000 have lost their lives…literally every minute we lose a woman to this disease, the majority, about 70-80% are in low and middle income countries and nearly half of these are premature deaths before the age of 70years. The impact is devastating to families and society at large..
The global breast cancer initiative if implemented could save 2.5M lives by 2040 through mortality reduction. Indeed, the recent investment case by WHO EMR demonstrated a return of between 6.4-7.8 USD for each dollar spent on breast cancer early diagnosis and treatment and an economic loss of USD 408B by 2050 if the status quo persists.
This week hosted the World Economic Forum at Davos as well as the High-Level Dialogue on women’s cancer in Egypt convened by the Presidential Initiative for Women’s Health on the sidelines of the 17th Breast and Gynaecological Cancer International Conference BGICC2025.
I attended the later and it was great interacting with colleagues and friends. It’s amazing to see in Egypt how political goodwill can transform society.. already the key performance indicators are being achieved and with sustained efforts the country will be on track to achieve a 2.5% per year reduction in breast cancer mortality by 2040. This requires collaboration and bringing everyone on board to ensure access to care and universal health coverage is achieved. We urge all governments to adopt and implement the GBCI and save women, generations and build our economies.
The time for action is now..”
IARC:
“IARC scientists Dr Valerie McCormack & Dr Partha Basu are pleased to support the Breast Gynecological & Immunooncology International Cancer Conference-BGICC, & to discuss research collaborations with Egypt’s Presidential Initiative for Women’s Health.”
“This is my second year attending BGICC in Cairo, and once again, I find the congress incredibly valuable and insightful for oncologists in the MENA region. The level of speakers is outstanding, and the quality of scientific discussions and insights is truly impressive.
I’m delighted to see how MSD contributes to this remarkable event through numerous scientific sessions and activities. A heartfelt thanks to my dear MSD colleagues in Egypt for their incredible hospitality and drive, and a special shukran to the medical team for their exceptional professionalism and leadership in improving patients’ lives.”
“Thrilled to have been part of BGICC 2025!
The sessions were packed with cutting-edge insights, innovative ideas, and discussions around the future of the industry. I’m grateful for the opportunity to learn, network, and collaborate with so many brilliant minds.
Events like these are a great reminder of the power of continuous learning and staying updated on the latest trends. Looking forward to applying the knowledge gained and staying connected with the amazing people I met!”
“I attended the 17th Breast Gynecological & Immunooncology International Cancer Conference-BGICC 2025 in Hilton Cairo Heliopolis and it was an incredible experience. The conference had very useful about cancer research and treatment. The speakers were experts and shared important updates. It was a good chance to learn and stay updated on the latest developments in oncology.”
“It was a great opportunity to attend the 17th BGICC 2025 – the renowned Breast Gynecological & Immunooncology International Cancer Conference-BGICC, known as the largest and most prestigious cancer conference in Africa and the Middle East.
Exploring cutting-edge topics including:
– Next Generation Sequencing: Popular Applications In Clinical Medicine.
– Genomics In Action: Data Sharing, Innovation, And Value Creation.
– AI Everywhere Transforming Genomics From Lab To Market.”
“Thrilled to have been part of BGICC 2025, blending my expertise as a pharmacist and media buyer to support impactful initiatives in innovation.
Being surrounded by such dedicated professionals and cutting-edge ideas was truly inspiring. Here’s to advancing science, healthcare, and meaningful collaborations!”
“Had an incredible time attending the Breast Gynecological & Immuno-Oncology International Cancer Conference (BGICC) in Cairo on January 23rd and 24th! It was such a thrilling experience to be surrounded by leading experts, sharing knowledge, and diving deep into the latest breakthroughs in cancer research. Grateful for the opportunity to connect with like-minded professionals and be part of such an inspiring global community!”
“I am excited to share that I had the incredible opportunity provided by Molecular Genomics Unit – MASRI and Dr Sara Hassan Agwa to attend the Breast-Gynecological & Immuno-oncology International Cancer Conference (BGICC) this year. It was truly inspiring to be surrounded by brilliant minds and engage in discussions on cancer research and treatment.
The event included several sessions presented by experts on topics such as genome sequencing and its transformative role in personalized medicine. These sessions emphasized how advancements in genetic research are revolutionizing oncology, opening new doors for targeted therapies and early detection.
I’m thankful for the chance to expand my knowledge, gain new insights, and connect with professionals who share the same passion for advancing science and medicine. I am looking forward to applying this knowledge in my journey and contributing to a better future in healthcare.”
“I’m honored to have attended the BGICC 2025 with a kind invitation from Molecular Genomics Unit – MASRI .
A heartfelt thank you to Dr. Sara Hassan Agwa and Dr.Mahmoud Ashraf for this opportunity and for their support throughout the event. It was a privilege to learn from global experts, explore the latest advancements in oncology, and connect with passionate professionals working to improve cancer care.
Grateful for this inspiring experience and excited to apply the knowledge gained to make a positive impact.”
“I am deeply impressed and inspired by the incredible Sessions at Breast Gynecological & Immunooncology International Cancer Conference-BGICC, Specially the insightful sessions which were organized by Medical Ain Shams Research Institute – MASRI
The discussions on Next-Generation Sequencing (NGS) truly showcased the transformative potential of genomics in reshaping clinical medicine, particularly in cancer research. It was enlightening to learn how NGS is revolutionizing precision medicine and personalized healthcare.
A standout moment was the session titled “Comprehensive Insights into Cancer Genomes with Oxford Nanopore Technologies” with Oxford Nanopore Technologies by Ashan Musafer. The session, focused on Third-Generation Sequencing , was nothing short of transformative, demonstrating how their sequencing technology is shaping both the present and the future of clinical medicine.
It was particularly powerful to witness the discussions around the implementation of Oxford Nanopore sequencing in cancer research, along with their groundbreaking advancements in protein sequencing techniques. Special thanks to all the organizers and chairpersons for their exceptional efforts and dedication in making this event a resounding success! Dr Enas A. Fouad ElHady, Dr Sara Hassan Agwa and Dr Samar Kamal.”
“I am very happy to attend the BGICC 2025 conference, one of the most important international conferences in the field of breast cancer and women’s tumors.
The conference was a great opportunity for learning and development, especially with the presence of a group of researchers, doctors and specialists from all over the world. I learned about the latest therapeutic techniques and innovations that contribute to improving patients’ lives, and there were very inspiring scientific discussions.
Attending this conference helped me expand my knowledge and build relationships with people who are passionate about scientific research and development in the field of medicine and cancer sciences. Science is a never-ending journey, and every step we take today contributes to a better future.
A big thank you to all those in charge of organizing the conference, and to all the participants who contributed their experiences and ideas.”
“It was my extreme pleasure to participate in BGICC 2025.. however it got more special by meeting old genuine friends..”
“Delighted to Attend BGICC 2025
I am thrilled to have participated in the Cairo Breast Cancer and Women’s Health International Conference (BGICC), one of the most influential conferences in the field of oncology.
This event brought together leading experts, researchers, and healthcare professionals from across the globe to discuss advancements in breast cancer treatment, cutting-edge technologies, and innovative approaches to improve patient outcomes.
For me, attending BGICC was an incredible opportunity to expand my knowledge, network with inspiring professionals, and explore new horizons in research and medical practices.
I truly believe that such platforms are vital for fostering collaboration, exchanging ideas, and driving progress in the fight against cancer.
A big thank you to the organizers, speakers, and everyone who made this event a success!
If you’d like to hear more about the conference highlights or the insights I gained, feel free to connect and reach out. Let’s grow and learn together!”
“Thrilled to have been part of BGICC 2025!
The sessions were packed with cutting-edge insights, innovative ideas, and discussions around the future of the industry. I’m grateful for the opportunity to learn, network, and collaborate with so many brilliant minds.
Events like these are a great reminder of the power of continuous learning and staying updated on the latest trends. Looking forward to applying the knowledge gained and staying connected with the amazing people I met!”
“Thrilled to have been a part of the impactful BGICC conference! This year, I had the opportunity to contribute as a panelist for the ‘Genomics in Action’ session, which sparked some fantastic discussions. I also presented our current work on ‘Exosomal ncRNAs as Translational Biomarkers in the Era of Genomics in Action’.
BGICC consistently provides an exceptional platform for researchers and experts in the region, and I always feel privileged to participate and share our work.”
“Highlights from the 17th BGICC Conference.
I recently attended the 17th Breast Gynecological & Immunooncology International Cancer Conference (BGICC) under the supervision of the Molecular Genomics Unit – MASRI, where I had the privilege of engaging with global experts and exploring groundbreaking advancements in genomics and cancer therapy as we discussed HRD characterization in various cancers with Prof. Fabio Pagni (Italy) and i improved my information by lectures of Dr. Oriol Casagran de la Cruz (Spain) on transforming PGT-A with the PG-Seq KIT, Dr. Ashan Musafer (USA) on nanopore sequencing in cancer, and Prof. Pantelis Constantoulakis (Greece) on genomic profiling. I am deeply grateful to them for sharing their invaluable knowledge and insights
I also want to express my gratitude to Prof. Mohamed Seadawy for his amazing presentation about precision medicine and drug resistance, Prof. Hend M. El Tayebi for sharing insights on transcriptomics and small-molecule inhibitors for personalized therapy in triple-negative breast cancer and Prof. Sherine El Daly for discussing exosomal and non-exosomal miRNAs as lung cancer biomarkers.
I also get the opportunity to know about recent innovative technologies of pharmaceutical companies as Dr. Fatma Zaki from Al Esraa Pharmaceuticals discussed the mechanism of Sucrosomial Iron product that uses Sucrosomial technology to help patients with iron deficiency, additionally Dr. Marwa and (china) from BGI Genomics, told us about SENTIST™ Cancer + Discovery from which is NGS-based solution for identifying cancer mutations to tailor the best treatment options.
Finally, i am very thanks to Prof. Sara Hassan Agwa and her team for their incredible efforts in developing Egyptian biological Kits to support researchers and reduce costs. This conference was a transformative experience, showcasing the power of collaboration, and I look forward to more opportunities for collaboration in the future.”
Further Reading:
Highlights from the 17th BGICC: Day 1 of Breast-Gynecological International Cancer Conference
How Egypt is closing the gap in breast cancer care: Dr. Hesham El-Ghazaly leads the conversation
Debate Highlights by Julie Gralow: Is There a Role for Immunotherapy in Early-Stage TNBC?
Scientific Insights from Prof. Hope Rugo: Advancements in Metastatic HER2+ Breast Cancer Therapy
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023